Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share
-
Shares outstanding
-
49,720,826
-
Total 13F shares
-
6,635,216
-
Share change
-
+6,635,216
-
Total reported value
-
$66,751,000
-
Price per share
-
$10.06
-
Number of holders
-
14
-
Value change
-
+$66,751,089
-
Number of buys
-
14
Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) as of Q2 2019
As of 30 Jun 2019,
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,635,216 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, Atlas Venture Advisors, Inc., Aquilo Capital Management, LLC, VICTORY CAPITAL MANAGEMENT INC, Polar Capital LLP, Laurion Capital Management LP, BlueCrest Capital Management Ltd, Pentwater Capital Management LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.